Terumo to distribute Biocompatibles' Bead Block:
This article was originally published in Clinica
UK device company Biocompatibles International has signed an exclusive global distribution deal for its PVA microsphere, Bead Block, which is used in embolisation therapy to block blood flow to tumours or vascular malformations. The agreement extends an existing partnership under which Terumo was appointed European distributor of the product in March. Terumo's worldwide sales of interventional products totalled $290m in fiscal 2003. Biocompatibles recently declared it had overcome manufacturing problems for Bead Block, although it admitted the product was really a stepping stone on the way to exploiting the bead technology in drug delivery applications (see Clinica No 1074, p 16).